Baird Medical Investment Holdings Limited (BDMD) - Total Assets
Based on the latest financial reports, Baird Medical Investment Holdings Limited (BDMD) holds total assets worth $76.99 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check BDMD capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Baird Medical Investment Holdings Limited - Total Assets Trend (2019–2024)
This chart illustrates how Baird Medical Investment Holdings Limited's total assets have evolved over time, based on quarterly financial data. Check Baird Medical Investment Holdings Limite earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Baird Medical Investment Holdings Limited - Asset Composition Analysis
Current Asset Composition (December 2024)
Baird Medical Investment Holdings Limited's total assets of $76.99 Million consist of 78.8% current assets and 21.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.8% |
| Accounts Receivable | $46.58 Million | 59.7% |
| Inventory | $1.30 Million | 1.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $16.53K | 0.0% |
| Goodwill | $57.77K | 0.1% |
Asset Composition Trend (2019–2024)
This chart illustrates how Baird Medical Investment Holdings Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BDMD company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Baird Medical Investment Holdings Limited's current assets represent 78.8% of total assets in 2024, an increase from 73.7% in 2019.
- Cash Position: Cash and equivalents constituted 3.8% of total assets in 2024, up from 1.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 1.0% in 2019.
- Asset Diversification: The largest asset category is accounts receivable at 59.7% of total assets.
Baird Medical Investment Holdings Limited Competitors by Total Assets
Key competitors of Baird Medical Investment Holdings Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Baird Medical Investment Holdings Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.71 | 1.77 | 0.06 |
| Quick Ratio | 1.67 | 1.74 | 0.06 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $25.28 Million | $26.79 Million | $-6.84 Million |
Baird Medical Investment Holdings Limited - Advanced Valuation Insights
This section examines the relationship between Baird Medical Investment Holdings Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.95 |
| Latest Market Cap to Assets Ratio | 0.43 |
| Asset Growth Rate (YoY) | 37.5% |
| Total Assets | $77.96 Million |
| Market Capitalization | $33.80 Million USD |
Valuation Analysis
Below Book Valuation: The market values Baird Medical Investment Holdings Limited's assets below their book value (0.43x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Baird Medical Investment Holdings Limited's assets grew by 37.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual total assets of Baird Medical Investment Holdings Limited from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $77.96 Million | +37.48% |
| 2023-12-31 | $56.71 Million | +33.06% |
| 2022-12-31 | $42.62 Million | +63.15% |
| 2021-12-31 | $26.12 Million | +53.51% |
| 2020-12-31 | $17.02 Million | +44.71% |
| 2019-12-31 | $11.76 Million | -- |
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more